3
Announcements
Trials
Browse
Landscape
Status
Completed
180
Recruiting
72
Unknown
38
Terminated
36
Active not recruiting
27
Not yet recruiting
11
Withdrawn
6
Suspended
2
Available
2
Enrolling by invitation
1
Approved for marketing
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
11
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
39
Stomach Neoplasms
20
Carcinoma, Hepatocellular
20
Pancreatic Neoplasms
15
Colonic Neoplasms
13
Esophageal Neoplasms
10
Liver Neoplasms
9
Rectal Neoplasms
8
Esophageal Squamous Cell Carcinoma
8
Cholangiocarcinoma
8
Breast Neoplasms
8
Barrett Esophagus
8
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
5
Postoperative Complications
4
Liver Cirrhosis
4
Gastrointestinal Neoplasms
4
Gallbladder Neoplasms
4
Diabetes Mellitus
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Lymphatic Metastasis
3
Lung Neoplasms
3
Fibrosis
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Anastomotic Leak
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Head and Neck Neoplasms
×
Gastrointestinal
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled